Pancreatic Cancer Research

ResearcherCentral South UniversityNo recent work listed

Weijia Sun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9395-5548; OpenAlex author ID A5101897386. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 2 papers · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 9

  1. Correction: MiR-142 modulates human pancreatic cancer proliferation and invasion by targeting hypoxia-inducible factor 1 (HIF-1α) in the tumor microenvironment… Co-author DOI 10.1242/bio.059951↗
  2. Downregulation of ULK1 by microRNA-372 inhibits the survival of human pancreatic adenocarcinoma cells. Last author DOI 10.1111/cas.13315↗
  3. MiR-142 modulates human pancreatic cancer proliferation and invasion by targeting hypoxia-inducible factor 1 (HIF-1α) in the tumor microenvironments. Co-author DOI 10.1242/bio.021774↗
  4. Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1007/s12253-015-9930-y↗
  5. miR-193b directly targets STMN1 and uPA genes and suppresses tumor growth and metastasis in pancreatic cancer. Last author DOI 10.3892/mmr.2014.2558↗
  6. MicroRNA-424-5p suppresses the expression of SOCS6 in pancreatic cancer. Last author DOI 10.1007/s12253-013-9637-x↗
  7. ADAM15 is involved in MICB shedding and mediates the effects of gemcitabine on MICB shedding in PANC-1 pancreatic cancer cells. Last author DOI 10.3892/mmr.2013.1272↗
  8. miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway. Last author DOI 10.1007/s13277-012-0446-8↗
  9. Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer. Last author DOI 10.1007/s12032-010-9480-9↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yebin Lu · 4 shared papers, 2011–2023 · strength 0.40
  2. Xuejun Gong · 2 shared papers, 2017–2023 · strength 0.30
  3. Xitao Wang · 1 shared paper, 2023 · strength 0.22
  4. Kemin Wu · 4 shared papers, 2012–2015 · strength 0.19
  5. Kun Song · 3 shared papers, 2014–2017 · strength 0.18
  6. Guo‐Huang Hu · 2 shared papers, 2013–2015 · strength 0.10
  7. Jian Li · 2 shared papers, 2013–2014 · strength 0.09
  8. Xiaohui Duan · 2 shared papers, 2011–2013 · strength 0.09
  9. Xitao Wang · 1 shared paper, 2017 · strength 0.08
  10. Hongxi Chen · 1 shared paper, 2017 · strength 0.08
  11. Yongjun Hu · 2 shared papers, 2011–2012 · strength 0.07
  12. Jian Li · 1 shared paper, 2015 · strength 0.06
  13. Yuxiang Chen · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.